INHIBRX BIOSCIENCES INC (INBX) Stock Cash Flow
NASDAQ:INBX - Nasdaq - US45720N1037 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 1.64B | -241.36M | -145.23M | -81.77M | -76.12M | |||
| Depreciation Amortization | 1.90M | 1.19M | 1.23M | 1.20M | 1.02M | |||
| Change In Working Capital | 80.41M | 15.35M | 3.16M | -17.52M | 12.69M | |||
| Interest Paid | N/A | 26.72M | 13.09M | 3.89M | 500.00K | |||
| Taxes Paid | N/A | 3.00K | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | -1.93B | 31.51M | 25.54M | 17.77M | 14.45M | |||
| OPERATING CASH FLOW | -207.51M | -193.31M | -115.30M | -80.32M | -47.97M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -6.02M | -4.59M | -690.00K | -860.00K | -1.36M | |||
| Other Investing Activity | N/A | N/A | 0.00 | 60.00K | N/A | |||
| INVESTING CASH FLOW | -6.02M | -4.59M | -690.00K | -810.00K | -1.36M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 128.86M | 39.99M | 41.36M | |||
| Stock Issued/Repurchased | 72.76M | 202.32M | 130.13M | 44.16M | 136.88M | |||
| Other Financing Activity | N/A | -355.00K | -440.00K | -380.00K | -11.78M | |||
| FINANCING CASH FLOW | 72.54M | 201.96M | 258.55M | 83.77M | 166.46M | |||
| CHANGE IN CASH | -140.99M | 4.06M | 142.56M | 2.64M | 117.13M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -207.51M | -193.31M | -115.30M | -80.32M | -47.97M | |||
| Capital Expenditure | -6.02M | -4.59M | -690.00K | -860.00K | -1.36M | |||
| FREE CASH FLOW | -213.53M | -197.90M | -115.99M | -81.18M | -49.33M | |||
All data in USD